Future Medicine Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	3,220	4,471	3,163
Short-Term Investments	3,054	3,000	-
Cash & Short-Term Investments	6,273	7,471	3,163
Cash Growth	-16.02%	136.18%	-
Accounts Receivable	0	-0	14.85
Other Receivables	83.77	119.28	0.39
Receivables	83.77	119.27	15.24
Prepaid Expenses	344.51	43.42	93.63
Other Current Assets	8.66	2.62	11.62
Total Current Assets	6,710	7,636	3,284
Property, Plant & Equipment	671.81	769.28	895.61
Long-Term Investments	143	143	143
Other Intangible Assets	612.16	364.56	199.74
Long-Term Accounts Receivable	-0	-	-0
Other Long-Term Assets	201.22	191.83	322.61
Total Assets	8,339	9,105	4,845
Accrued Expenses	49.14	32.69	28.1
Short-Term Debt	-	6,834	-
Current Portion of Leases	157.25	150.14	124.32
Current Unearned Revenue	7.51	7.51	-
Other Current Liabilities	375.76	14,592	5,499
Total Current Liabilities	589.67	21,617	5,651
Long-Term Debt	-	1,900	8,626
Long-Term Leases	106.42	222.01	336.08
Other Long-Term Liabilities	221.68	75	-0
Total Liabilities	1,160	23,923	14,853
Common Stock	4,638	3,413	1,517
Additional Paid-In Capital	48,379	11,854	11,383
Retained Earnings	-46,922	-33,897	-23,395
Comprehensive Income & Other	1,083	645.69	486.46
Total Common Equity	7,178	-17,985	-10,009
Shareholders' Equity	7,178	-14,818	-10,009
Total Liabilities & Equity	8,339	9,105	4,845
Total Debt	263.67	9,106	9,087
Net Cash (Debt)	6,010	-1,635	-5,924
Net Cash Per Share	795.88	-252.66	-976.37
Filing Date Shares Outstanding	9.28	6.83	6.07
Total Common Shares Outstanding	9.28	6.83	6.07
Working Capital	6,121	-13,981	-2,367
Book Value Per Share	773.88	-2634.67	-1649.72
Tangible Book Value	6,566	-18,350	-10,208
Tangible Book Value Per Share	707.88	-2688.07	-1682.65
Machinery	623.67	498.08	412.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.